3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Lung Neoplasms
9
Small Cell Lung Carcinoma
6
Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoma
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms by Site
3
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Neoplasms by Histologic Type
2
Liver Neoplasms
2
Gallbladder Neoplasms
2
Bile Duct Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Interventions
Cyclophosphamide
23
fludarabine
15
fludarabine phosphate
10
Methotrexate
10
blinatumomab
9
Whole-Body Irradiation
9
Vincristine
7
Specimen Handling
7
Dexamethasone
7
merphos
6
Tacrolimus
6
Mycophenolic Acid
6
Stem Cell Transplantation
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Mercaptopurine
5
Melphalan
5
Leukapheresis
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cytarabine
5
Cyclosporine
5
Biopsy
5
pegaspargase
4
Prednisone
4
Magnetic Resonance Spectroscopy
4
Etoposide
4
Calcium Dobesilate
4
Busulfan
4
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
durvalumab
×
30 days
×
Clear all
No trials found.